Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Dana Gabuzda, M.D.

Concepts (573)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Dana Gabuzda's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Dana Gabuzda has written about over time.
Gene Products, vif, 15 publications between 1992 and 2006, average publication date September 1999. vif Gene Products, Human Immunodeficiency Virus, 19 publications between 1992 and 2015, average publication date November 2001. Monocytes, 17 publications between 1987 and 2012, average publication date June 2002. Virus Replication, 36 publications between 1990 and 2015, average publication date July 2002. Macrophages, 28 publications between 1987 and 2018, average publication date July 2003. HIV, 13 publications between 1986 and 2023, average publication date January 2004. HIV-1, 84 publications between 1990 and 2022, average publication date March 2004. Receptors, CCR5, 20 publications between 1997 and 2015, average publication date May 2004. HIV Envelope Protein gp120, 16 publications between 1991 and 2015, average publication date June 2004. Receptors, IgG, 7 publications between 2003 and 2009, average publication date February 2006. CD4-Positive T-Lymphocytes, 14 publications between 1992 and 2023, average publication date June 2006. AIDS Dementia Complex, 25 publications between 1990 and 2019, average publication date April 2007. Cytidine Deaminase, 7 publications between 2003 and 2015, average publication date December 2008. nef Gene Products, Human Immunodeficiency Virus, 9 publications between 2006 and 2012, average publication date December 2008. Simian Immunodeficiency Virus, 5 publications between 1999 and 2018, average publication date February 2011. HIV Infections, 55 publications between 1990 and 2024, average publication date May 2013. Antiretroviral Therapy, Highly Active, 9 publications between 2009 and 2021, average publication date February 2017. Interferons, 4 publications between 2012 and 2019, average publication date April 2017.

To see the data from this visualization as text, click here.
Gabuzda's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (573)
Explore
_
Co-Authors (35)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.